Anika Therapeutics, Inc.
ANIK
$9.76
-$0.12-1.22%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.33M | -3.97M | -4.87M | -- | -- |
| Total Depreciation and Amortization | 1.40M | 1.27M | 1.59M | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.39M | 6.35M | 3.42M | -- | -- |
| Change in Net Operating Assets | 4.41M | -3.83M | -269.00K | -- | -- |
| Cash from Operations | 6.87M | -189.00K | -130.00K | -- | 5.02M |
| Capital Expenditure | -1.89M | -1.47M | -2.82M | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 0.00 | 4.50M | -- | -- | -- |
| Other Investing Activities | 155.00K | -3.57M | 4.50M | -- | -- |
| Cash from Investing | -1.73M | -539.00K | 1.67M | -- | -1.82M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 261.00K | -- | -- | -- |
| Repurchase of Common Stock | -13.00K | -82.00K | -5.44M | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -13.00K | 179.00K | -5.44M | -- | -3.99M |
| Foreign Exchange rate Adjustments | -302.00K | 345.00K | 108.00K | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.82M | -204.00K | -3.79M | -- | -454.00K |